AID also plays an essential role in the progression of Philadelphia-positive (Ph+) leukemias, including chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL) [6, 7]. Here, AICDA is linked to chronic myelogenous leukemia, BCR-ABL1 positive.